SKF 94901
Alternative Names: SKF L94901Latest Information Update: 14 Dec 1994
At a glance
- Originator GlaxoSmithKline
- Class Antihyperlipidaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia